FDA issues order prohibiting antimicrobial drug in poultry
The US Food and Drug Administration (FDA) has published
a final rule that prohibits the extralabel use of cephalosporin antimicrobial
drugs in food-producing animals, including chickens, turkeys, cattle and swine.
According to the FDA, this rule will help protect consumers against
antimicrobial-resistant strains of zoonotic foodborne bacterial pathogens.
By law, the FDA may issue a prohibition order if evidence shows that
extralabel use of a drug in food-producing animals has caused, or is likely to
cause, a public health risk. In this case, the FDA has gathered evidence showing
that the extralabel use of cephalosporins in food-producing animals is likely to
contribute to the emergence of resistance and compromise human therapies.
Given the importance of the cephalosporin class of drugs for treating
disease in humans, FDA believes that preserving the effectiveness of such drugs
is critical. The agency therefore believes that it is necessary to take action
to limit the extent to which extralabel use of cephalosporins in food-producing
animals may be contributing to the emergence of resistant variants.
The prohibition of extralabel use of cephalosporin antimicrobial drugs in
food-producing animals will protect the public health by preserving the
effectiveness of cephalosporin-class drugs for the treatment of human
Comments on the rule may be submitted until 2 September, 2008, and the rule
will go into effect on 1 October, 2008.
To comment, login here
Or register to be able to comment.